Statistical comparison between dissolution profiles of drug products

Area of Science:

• Pharmaceutical Sciences
• Biostatistics

Background:

• Traditional methods for assessing drug dissolution profile similarity face challenges with undefined equivalence limits and time-point correlations.
• Existing advanced methods like repeated measures and multivariate analysis are sensitive to time point selection and complex error structures.

Purpose of the Study:

• To propose novel equivalence limits for dissolution profile similarity assessment.
• To introduce a time series approach that accounts for correlations between dissolution data points.
• To provide a statistically robust method for evaluating drug product similarity.

Main Methods:

• Review of existing model-dependent and model-independent dissolution profile assessment methods.
• Proposal of equivalence limits based on United States Pharmacopeia and National Formulary (USP/NF) standards for dissolved active ingredient.
• Development and application of a time series statistical model to analyze dissolution data.

Main Results:

• The proposed equivalence limits and time series model effectively address limitations of classical methods.
• The new approach accounts for the correlation between dissolution results at different time points.
• Demonstrated utility of the method using a case study of two drug product lots.

Conclusions:

• The proposed time series approach offers a more reliable method for assessing similarity between drug product dissolution profiles.
• This methodology enhances the accuracy and robustness of pharmaceutical quality control.
• The study provides a valuable tool for regulatory compliance and drug product development.